Alexander Hillisch

Alexander Hillisch is an accomplished pharmaceutical professional currently serving as the Head of Global CADD and Executive Director at UCB since January 2023. With extensive experience spanning over two decades, Hillisch has held various leadership positions, including Vice President and Head of Computational Molecular Design at Bayer until December 2022, where contributions included coauthoring 63 pharmaceutical compound patents leading to six clinical development candidates. Additionally, Hillisch has been an Honorary Professor at Universität zu Köln since 2010, actively teaching and mentoring at multiple universities. This expertise is complemented by a strong background in digital technologies and drug design methodologies, with prior roles at EnTec GmbH and the Institute of Molecular Biotechnology e.V. Hillisch earned a Mag. pharm. degree in Pharmacy from the University of Vienna.